As on: Aug 24, 2026 05:19 PM
The Board of Directors are pleased to present the annual report consisting of highlights on the business and operations of the Company, along with the audited financial statements, for the Financial Year ended March 31, 2026.
FINANCIAL YEAR
The Board of Directors of the Company, on January 23, 2025, had approved the change in Financial Year of the Company from "July 1 - June 30" period to "April 1 - March 31" period. The Financial Year of the Company for period under review, viz., 2025-26, commenced on April 1, 2025, and ended on March 31, 2026.
FINANCIAL RESULTS
The Company's financial performance for the Financial Year ended March 31, 2026 is summarized below:
(in ' Crores)
MANAGEMENT DISCUSSION & ANALYSIS: BUSINESS PERFORMANCE AND STRATEGY
*Previous Financial Year 2024-25 was a 9-month period from July 1, 2024, to March 31, 2025, and hence not comparable with current Financial Year 2025-26 (being 12-month Financial Year from April 1, 2025, to March 31, 2026).
DIVIDEND
During the Financial Year, the Board of Directors of the Company, at its meeting held on January 30, 2026, declared an interim dividend of Rs.195 per equity share (including one-time special dividend of Rs. 25 per equity share), which was paid on February 26, 2026.
The Board of Directors of the Company, at its meeting held on May 28, 2026, have recommended a final dividend of Rs. 60 per equity share, for the Financial Year ended March 31, 2026. This final dividend is subject to the approval of the Members at the ensuing 62 nd Annual General Meeting of the Company.
The aggregate dividend for the Financial Year ended March 31, 2026 (including the afore-mentioned interim and final dividend), amounts to Rs.255 per equity share.
During the Financial Year, the Company continued to strengthen its focus on consumers through meaningful innovation across its feminine care and healthcare portfolios, while remaining committed to the disciplined execution of our integrated growth strategy. The Company delivered a balanced growth with reported revenue of Rs. 4,290 crores and Profit After Tax (PAT) of Rs. 857 crores. This year's results showed targeted investments, with continued focus on consumer centric innovations and strengthening its go-to-market capabilities.
The Company continues to remain focused on Long term value creation and to better serve consumers, customers, employees, society, and shareholders, through its integrated growth strategy, which consists of five strategic and integrated choices:
• A focused product portfolio where performance drives brand choice;
• Irresistible superiority across product, package, brand communication, retail execution and value, to delight consumers;
• Productivity improvement in all areas of our operations;
• Leading constructive disruption of our industry across all areas of the value chain; and
• An empowered, agile and accountable organization, enabling us to better serve consumers.
These strategic choices reinforce and build on each other. When these strategic choices are executed well, they grow markets while creating business, which in turn, grows Company's share, sales, household penetration and profit. Importantly, this strategy is inherently dynamic. It adapts to the changing needs of stakeholders. It demands that we do not sit still.
FEMININE HYGIENE BUSINESS
The feminine hygiene category continues to evolve, driven by changing consumer expectations and increasing demand for products that deliver superior performance, comfort and protection. The Company
remains committed to serving consumers through continuous innovation, offering high-quality products that address their evolving needs while reinforcing consumer trust in the Whisper brand.
Through its robust portfolio comprising of Whisper Bindazzz Nights, Whisper Choice, Whisper Choice Nights, Whisper Ultra, Whisper Period Panty and others, the Company aims to deliver superior product experiences that enhance consumer comfort, confidence and well-being. The Company remains focused on continuously enhancing and upgrading its propositions across product formats, ranges and pack sizes to elevate consumer experience and satisfaction.
The Whisper Period Panty portfolio, a differentiated offering within the category, is designed to provide 360-degree leakage protection for heavy flow days, along with enhanced absorption and a soft, breathable waistband for improved comfort, the portfolio continues to address evolving consumer needs and strengthen the Company's presence in the premium segment.
The Company continues to Leverage consumer insights and scientific understanding of menstruation, to develop products that address specific consumer needs. The Company recognized that menstrual flow
patterns differ between day and night, and that women are constantly stressed about frequent Leaks during period night, yearning for a peaceful, comfortable sleep during periods. To alleviate such concerns and provide Bindazzz nights to consumers, the Company has been upgrading and bettering its Whisper Nights portfolio across price ranges, to ensure absolute consumer delight. During the year, the Bindazzz Nights and Choice Nights portfolio continued to be strong growth drivers serving consumers needs for a longer, wider product to be used in their most critical moments giving them coverage and reassurance of absorption.
The Company also continued to strengthen consumer engagement through integrated communication initiatives focused on addressing consumer concerns, misconceptions and barriers to informed purchase decisions. Leveraging expert-led and credible voices across multiple consumer touchpoints, these campaigns reinforced awareness of product benefits and superiority, enabling consumers to make informed choices with greater confidence.
The Company remains committed to addressing the diverse challenges faced by menstruators through awareness-building initiatives, consumer education and efforts aimed at breaking taboos and myths surrounding menstruation. Through these initiatives and continued portfolio activations, the Company seeks to strengthen brand equity while remaining focused on delivering sustainable growth and meaningful consumer value.
HEALTH CARE BUSINESS
The Company's health care portfolio is also designed with a consumer-first approach, offering a diverse range of products that address various needs, from single and multiple symptoms to customized solutions in various forms. Vicks has served many generations of consumers, and it continues to deliver comfort through its extensive range of superior- quality products. The Company's health care portfolio includes Vicks VapoRub, Vicks Cough Drops, Vicks Action 500 Advanced, Zzzquil, Vicks Inhaler, Vicks Xtra Strong Rub, Vicks Baby Rub, Vicks VapoRub Steam Pods, Vicks Headache Roll-on and Vicks Cough Syrup.
This was a strong year of growth for the iconic Vicks Rubs portfolio led by Vicks VapoRub in-continuation to the last year. The Company's strategy on focusing Vicks VapoRub's effectiveness in cough and cold symptom relief especially on children is continuing to deliver strong results. The Company elevated its execution in this year with its "All-Night Relief" campaign which resonated well with parents, reinforcing the product's essential role in providing relief for the kids during cough and cold.
Consumers continued to leverage the benefit of Vicks Inhaler for instant relief from blocked nose with natural ingredients menthol & camphor to meet the needs of consumers on-the-go.
Vicks Cough Drops Double Power continued to engage consumers through impactful campaigns. 'Vicks Khol, India Bol' anthem campaign aimed at cheering for India with a clear ' Khich-Khich ' free voice, also making it accessible in sign language with an aim that no voice is left unheard.
In response to the evolving consumer preferences for advanced cough and cold relief solutions, the Company recently launched Vicks Cough Syrup, a premium addition to its portfolio which signifies a synergy between science and tradition. This product is designed to cater to the growing demand for herbal and ayurvedic remedies, offering a unique formulation that combines ayurvedic wisdom with a modern form factor. With a non-drowsy formula that works effectively on both wet and dry cough, Vicks Cough Syrup represents Company's commitment to offering superior products to consumers within the cough and cold category.
During the year, Company upgraded its product Vicks ZzzQuil Natura Sleep Gummies. With consume insights, Company acknowledged that man consumers higher melatonin dosage and they have strong affinity to natural ingredients when it come to healthcare products. Accordingly, the upgrade' Zzzquil combines the best of both to provide bette
consumer experiences, by having combination of 5 mg of melatonin to help consumer fall asleep naturally, with 50 mg of natural ashwagandha to help calm their mind and body. Zzzquil continued to remain the top-selling product on e-commerce in the nutritional sleep supplements segment.
By addressing the needs of consumers seeking elevated and effective relief, the Company continued to build the category, during the Financial year.
OLD SPICE
Old Spice continued to build on its online momentum demonstrating strong growth across the 0% Gas Deodorants portfolio and After Shave Lotion portfolio. The Company recognizes that today's consumers crave real, relatable content and hence, the Company's collaboration with creators from diverse genres has resonated well and played a crucial role in driving demand generation and thereby delivering consistent growth on the brand.
ECONOMIC OUTLOOK, RISKS & OPPORTUNITIES
The International Monetary Fund's (IMF) July 2026 World Economic Outlook projects global growth at 3% in 2026. Growth is expected to be 3.4% in 2027.
This represents a V-shaped recovery pattern with a minor slowdown this year, balancing geo-political conflict shocks against artificial intelligence tech booms.
The IMF also projects that global headline inflation is expected to rise to 4.7% in 2026 up from 4.1% in 2025, before declining to 3.9% in 2027.
India is expected to remain the world's fastest growing major economy, with growth projected at 6.4% in 2026-27, driven by strong domestic demand.
While the Indian economy continues to grow stronger amidst all global peers, one must, however, keep an eye on the evolving global trade policies and commodity prices which will impact inflation and cost of goods produced.
Within the Indian Fast-Moving Consumer Goods (FMCG) industry, trends continue to evolve. While non-food Inflation continues to stay below RBI's medium-term target of 4%, consumer consumption trends are still shifting. While rural consumption continues to be higher than the urban consumption, we are seeing a softening trend driven by uptick in the inflation rates. Based on reports and economic analysis as of early 2026, the FMCG sector is expected to experience a stabilization phase, entering a period of renewed optimism, with projections focusing on volume-led growth rather than price-driven expansion. Consumption trends remain supportive. Urban demand continues to anchor growth, aided by premiumisation across categories.
In this environment, the Company continues to hold a cautiously optimistic outlook for the future and is well positioned to sustain and improve its performance with its integrated growth strategy and serve the consumers with superior products.
Source: IMF's World Economic Outlook report, July 2026
FINANCIAL RATIOS
The Company's financial performance for the Financial Year ended March 31, 2026, as compared to the previous year ended March 31, 2025, is summarized below:
* The numbers are not comparable as current year is a twelve month period vs. nine-month period in the previous year..
**The Company did not have any borrowings during the Financial Year, hence interest coverage ratio and debt equity ratio are not applicable.
RISK MANAGEMENT
The Company has set up a Risk Management Committee and has also adopted a risk management policy. Adequate measures have been adopted by the Company to anticipate, plan and mitigate the spectrum of risks it faces. The Company's risk management process focuses on ensuring that these risks are identified and addressed on a timely basis. The risks are identified by a consistent process across functions and the Company also strives to link each risk with a mitigation step to ensure business continuity. The risk report is reviewed at regular intervals, to ensure that risks are planned for mitigation, for the fact that not all risks can be eliminated.
As part of the business sustainability and governance process, in order to ensure a robust risk management system, in line with the applicable laws, the Company follows a proactive risk management policy, aimed at protecting its employees, assets and the environment, while at the same time ensuring growth and continuity of its business. The Company also has adequate insurance coverage to protect the value of
its assets. The Company has in place a very stringent and responsive system under which all its distributors and vendors are assessed before being selected.
SECURITY
The Company has implemented comprehensive security programs supported by latest technology and trained manpower to protect employees and assets, at all its offices and plant. During the Financial Year under review, no major security breaches or incidents occurred at the Company's plant. A comprehensive security risk assessment is carried out regularly and adequate security measures are implemented to cater to changing security scenario. The Company has installed the best of the security measures and processes to protect its personnel and assets.
REGULATORY AND COMPLIANCE
The Company operates within the letter and spirit of all applicable laws. General compliance with legal requirements is an important component of the Company's Worldwide Business Conduct Manual (WBCM) and the same expects the following from its employees:
To uphold our Purpose, Values, and Principles in our work and in the business decision we make
To do the right thing at all times
To follow standards set forth in the WBCM and the law at all times
To know and fully comply with the laws, regulations, and company policies that apply to the employees' work
To be alert to any situations or actions that may violate the law, the WBCM or Company policies, and to report them appropriately
The Company has set in place the requisite mechanism for meeting the compliance requirements, periodic monitoring of compliance to avoid any deviations, and regular updates to keep pace with the regulatory changes.
A number of training programs are conducted periodically for employees with respect to various compliance related topics such as Global AntiCorruption Standards, Prevention of Sexual Harassment at Workplace, Whistle-blower Mechanism, Conflict of Interest, Data Privacy, Data Integrity, Anti-Trust compliance etc.
INTERNAL CONTROLS & THEIR ADEQUACY
The Company continues to prioritize sustainable control processes that are an integral part of organization culture. It has built strong Internal Controls Environment and Risk Assessment and Management systems. These systems enable the Company to comply with Internal Company policies, procedures, standard guidelines, and local laws to help protect Company's assets and confidential information including personal identifiable information (PII) against financial losses and unauthorized use. The robust controls environment at the Company is efficiently managed and monitored through:
• Controls Self-Assessments (CSA)
CSAs are performed during the year across business processes. The purpose of this thorough exercise is to review and evaluate process compliances against standard control objective, activities, and attributes. This enables the Company to proactively identify control weaknesses and initiate actions to sustainably mitigate them. Along with CSAs, the Company also has a process of continuous monitoring controls in manufacturing processes via an internally developed toolkit that tracks control activities and assesses effectiveness of controls with the process owners by selecting auto samples for packing, planning, warehousing, etc. Samples are auto picked up every quarter for the respective areas in the toolkit and tested. Defects, if any, are reviewed by the management. This ensures ongoing monitoring of controls for operational areas.
• Governance and Global Internal Audit (GIA)
There are internal control experts in the organization guiding business teams on day-to-day compliance requirements. They
also ensure that all key processes, i.e. selling, distribution, trade & marketing expenses, vendor payments, etc. are reviewed and assessed at appropriate intervals via CSAs, standard operating procedures and process reviews or audits as applicable. As part of their ongoing monitoring process, if there are issues identified, those are reported to senior management for implementing action plans to strengthen control environment in these processes. The assessments of high-risk and SOX compliance areas are done by Company's Global Internal Audit (GIA) team. GIA comprises of certified internal auditors who have experience across different markets and have independent centers of excellence. Issues raised by internal audit teams are tagged to business owners and issue remediation is then reviewed and reported appropriately to the senior leadership.
• Governance Board
The Governance Board is led by the Managing Director and comprises Chief Financial Officer, Chief Human Resource Officer, Supply Chain Leader, Purchasing & Sustainability Leader, and Legal Counsel. The Governance Board assesses, and reviews enterprise level risks and works with process owners and functional managers to ensure that corrective action is taken, and risk is mitigated as appropriate.
BUSINESS RESPONSIBILITY, ENVIRONMENTAL SUSTAINABILITY AND CONSERVATION OF ENERGY
The Company believes that its efforts in
environmental sustainability are important to create superior propositions for consumers, customers, and shareholders, while improving its environmental impact. The Company continuously seeks to reduce the footprint of its operations and to enable consumers to reduce their footprint, when they use Company's products.
The Company's plant site at Goa is a zero manufacturing- waste-to-landfill site, which means that no manufacturing waste is discharged into the environment.
The Company contributes to the P&G group's ambition to reduce Greenhouse Gas emissions across its operations. The Company will continue to strive in its efforts towards this ambition.
The Company aims to reduce plastic packaging waste and to design the product packaging to be recyclable or reusable and to reduce the use of virgin petroleum plastic resin in consumer packaging.
The Company continues to be compliant with the Extended Producer Responsibility guidelines on plastic packaging waste collection.
The Company also aims to play its part in protecting the water resources and address the key challenges impacting its operations and the local communities where it operates in.
A separate report on Business Responsibility & Sustainability has been appended as Annexure I to this Report.
CORPORATE SOCIAL RESPONSIBILITY
The Company's flagship Corporate Social Responsibility program - P&G Shiksha is a holistic program that focuses on improving learning outcomes for children from underserved communities across the country. P&G Shiksha has streamlined its efforts to focus on improving learning outcomes, enabling every child to learn with conceptual understanding and realize their aspirations. P&G Shiksha uniquely remains single-mindedly focused on education, creating a deep and lasting impact.
The Company has constituted a Corporate Social Responsibility Committee. The composition and terms of reference of the Corporate Social Responsibility Committee are provided in the Corporate Governance Report annexed to this Annual Report.
Annual report on Corporate Social Responsibility activities as required under the Companies (Corporate Social Responsibility Policy) Rules, 2014 has been appended as Annexure II to this Report.
TECHNOLOGY ABSORPTION AND RESEARCH & DEVELOPMENT
The Company has the advantage of availing advanced technology and continuous upgradation thereof from The Procter & Gamble Company, USA and its subsidiaries. This is an unmatched competitive advantage that helps the Company deliver strong business results.
As the Company avails benefits of research and development of The Procter & Gamble Company, USA and its subsidiaries across the globe, the Company has not incurred any expenditure on research and development during the Financial Year. Technology absorption and adaptation is a continuous process. The products manufactured and sold by the Company are a result of such imported technology received on an ongoing basis. Initiatives are constantly undertaken for innovation of products, new product development, improvement of packaging, enhancement of product quality and application of best information technology to automate, simplify and generate efficiencies in various business processes.
The Company having ongoing access to cutting- edge technology, derives benefits such as product development, consistent superior product quality, process efficiencies, cost effectiveness and energy efficiency.
FOREIGN EXCHANGE EARNINGS & OUTGO
The details of foreign exchange earnings and outgo as required under Section 134 of the Companies Act, 2013 and Rule 8(3) of the Companies (Accounts) Rules, 2014 are mentioned below:
(' in crores)
RELATED PARTY TRANSACTIONS
The Company has formulated a policy on related party transactions which is also available on Company's website at https://in.pg.com/india-governance- and-policies/pghh/terms-and-policies/#policies . This policy deals with the review and approval of related party transactions. All related party transactions are placed before the Audit Committee for review and approval. Prior omnibus approval is obtained for related party transactions which are of repetitive nature and entered in the ordinary course of business and at arm's length. All related party transactions are subjected to independent review by Chartered Accountant firm to confirm compliance with the requirements under the Companies Act, 2013 and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Details of material related party transaction entered into during the Financial Year 2025-26 are given below:
Shareholders by passing an Ordinary Resolution at the
Annual General Meeting held on November 24, 2023. Being related parties, the Promoter shareholders had abstained from voting on the said resolution.
LOANS AND GUARANTEES GIVEN AND INVESTMENTS
The Company has not given any loans and guarantees or made any investments during the Financial Year.
PUBLIC DEPOSITS
The Company has not accepted any Public Deposits under Chapter V of the Companies Act, 2013, during the Financial Year.
DISCLOSURE UNDER SEXUAL HARASSMENT
OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013
As per the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 ("the Prevention of Sexual Harassment Act"), the Company has formulated a Policy on Prevention of Sexual Harassment at Workplace for prevention, prohibition and redressal of sexual harassment at workplace and has duly constituted Internal Complaints Committees for redressal of any such complaints received. The Company is committed to providing a safe work environment.
During the Financial Year, no complaint with allegation of sexual harassment was filed with the Company.
DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to the requirement under Sections 134(3) (c) of the Companies Act, 2013, with respect to the Directors' Responsibilities Statement, it is hereby confirmed:
i. that in the preparation of the Annual Accounts for the Financial Year ended March 31, 2026, the applicable accounting standards had been followed along with proper explanation relating to material departures;
ii. that the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that were reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the Financial Year and of the profit of the Company for the Financial Year under review;
iii. that the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013, for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
iv. that the Directors had prepared the accounts for the Financial Year ended March 31, 2026 on a "going concern" basis;
v. that the Directors had laid down internal financial controls to be followed by the Company and such internal financial controls are adequate and were operating effectively; and
vi. that the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
CORPORATE GOVERNANCE
A separate report on Corporate Governance along with the Auditors' Certificate on its compliance is annexed to this Report.
ANNUAL RETURN
The Annual Return for the Financial Year 2025-26, as required under Section 92(3) and Rule 12 of the Companies (Management and Administration) Rules, 2014 is available on the website of the Company at https://in.pg.com/india-investors/pghh/shareholder- info/info/ .
HUMAN RESOURCES
The Company continues to focus on creating an appealing employer brand, attracting talent that aligns with the Company's values, and nurturing that talent for future success. The Company has developed comprehensive employee centric human resource strategies, to ensure that our organization is well-prepared to meet future challenges.
India remains a critical talent source for the Company, and the Company has adapted our campus initiatives to proactively address the ever-evolving talent cohorts. The Company has launched innovative campus programs and revamped existing ones to continue to attract the best talent. The Company's internships, onboarding, and learning & development programs continue to receive recognition in various campus surveys. The Company is committed to nurturing our talent and fostering diverse leaders who will thrive in our ecosystem.
P&G India has been consistently recognized as an employer of choice. For the ninth consecutive year, AVTAR has acknowledged us as one of the top 100 companies for women in India. We have also received accolades such as the Buddies of Wellness by People Matters (2025), and Silver Employer for progress on LGBTQ+ inclusion at the Workplace by the India Workplace Equality Index (2025), among others. The number of employees as on March 31, 2026 was 386.
To foster a winning culture, it is crucial to engage and empower employees right from their comprehensive corporate onboarding program. By instilling a growth mindset , the Company encourages a love for learning and resilience, which are vital for achieving both organizational and personal goals.
Through its Equality & Inclusion chassis and holistic wellbeing program, the Company encourages its employees to bring their authentic selves to work. The Company strongly believes in co-creating careers with its employees, allowing them to collaborate with the business and achieve fulfilling careers.
The Company is compliant with the Maternity Benefit Act, 1961.
The statement of Disclosure of Remuneration under Section 197 of the Companies Act, 2013 and Rule 5 (1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is appended as Annexure III to this Report.
As per the provisions of first proviso to Section 136(1) of the Companies Act, 2013, the Report and Financial Statements are being sent to the Members of the Company excluding the statement of particulars of employees under Rule 5 (2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. Any Member interested in obtaining a copy of the said statement may write to the Company Secretary at investorpghh.im@pg.com .
DIRECTORS AND KEY MANAGERIAL PERSONNEL
During the Financial Year under review, Mr. Gagan Sawhney, Non-Executive Director stepped down from the Board of the Company, with effect from October 5, 2025.
Ms. Mrinalini Srinivasan ceased to be Chief Financial Officer of the Company with effect from June 30, 2025. Mr. Gaurav Bhartia was appointed Chief Financial Officer with effect from July 1, 2025.
The Board of Directors of the Company express their deepest gratitude to Ms. Mrinalini Srinivasan and Mr. Gagan Sawhney for their valuable guidance, counsel and direction to the Company during their tenure on the Board of the Company.
Mr. Pramod Agarwal, Director, retires by rotation and being eligible, offer himself for re-appointment at
the ensuing 62 nd Annual General Meeting. Appropriate resolution for his re-appointment is being proposed at the ensuing 62 nd Annual General Meeting, which the Board recommends for approval of the shareholders of the Company.
After the closure of the Financial Year, below changes were effected, as approved by the Board of Directors at their meeting held on May 28, 2026.
Mr. Ghanashyam Hegde ceased to be an Executive Director, Company Secretary and Compliance Officer of the Company effective June 30, 2026. He was re-designated as Non-Executive Director of the Company effective July 1, 2026.
Further, Mr. Gaurav Bhartia ceased to be the Chief Financial Officer of the Company effective June 30, 2026. Ms. Srividya Srinivasan was appointed as a Whole-time Director, effective July 1, 2026, for a period of five years subject to approval of Shareholders of the Company at the ensuing 62 nd Annual General Meeting of the Company. She is also appointed as the Chief Financial Officer of the Company effective July 1, 2026.
Brief Profiles and details of the directorships of Directors proposed to be appointed/re-appointed as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are contained in the Notice convening the ensuing 62 nd Annual General Meeting of the Company.
All Independent Directors of the Company have provided declarations to the Company stating that they meet the criteria of independence as mentioned under Section 149 (6) of the Companies Act, 2013 and the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 ["SEBI (LODR) Regulations, 2015"].
The Board is of the opinion that all the Independent Directors of the Company possess integrity, have relevant expertise and experience and fulfil the conditions specified under the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015. The details of the familiarization programmes and annual board evaluation process for Directors have been provided under the Corporate Governance section of the Report.
NUMBER OF MEETINGS OF BOARD OF DIRECTORS
Five (5) meetings of the Board of Directors of the Company were held during the Financial Year
2025-26. For further details on meetings of the Board of Directors and its Committees, please refer to the Corporate Governance section of the Annual Report.
POLICIES
The Company has adopted various policies, including policies on related party transactions, corporate social responsibility, vigil mechanism, nomination and remuneration, materiality of events and dividend distribution policy, which are available on the website of the Company at https://in.pg.com/ india-governance-and-policies/pghh/terms-and- policies/#policies .
AUDITORS INTERNAL AUDITOR
The Board of Directors had appointed Ms. Pooja Bhutra, Chartered Accountant as the Internal Auditor of the Company for the Financial Year 2025-26.
STATUTORY AUDITOR
At the Annual General Meeting held on November 15, 2022, M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants, were appointed as Statutory Auditors of the Company for a second term of five years, i.e., from the conclusion of the 58 th Annual General Meeting until the conclusion of the 63 rd Annual General Meeting.
The Report issued by M/s. Kalyaniwalla & Mistry LLP, Statutory Auditors on the financial statements of the Company for the Financial Year ended March 31, 2026, is part of the Report. There have been no qualification, reservation or adverse remark given by the Auditors in their Report.
COST AUDITORS
M/s. Ashwin Solanki & Associates, Cost Accountants carried out the cost audit as Cost Auditors for applicable business during the Financial Year 2025-26.
The Board of Directors of the Company, on the recommendation made by the Audit Committee, re-appointed M/s. Ashwin Solanki & Associates, as the Cost Auditors of the Company for the financial year 2026-27.
The resolution for ratification of the proposed remuneration payable to M/s. Ashwin Solanki & Associates to audit the cost records of the Company for the financial year ending March 31, 2027, is being placed for the approval of the shareholders of the Company at the ensuing 62 nd Annual General Meeting of the Company.
SECRETARIAL AUDIT
Secretarial Audit was carried out by M/s. Saraf & Associates, Practicing Company Secretaries for the Financial Year 2025-26. There were no qualifications, reservations or adverse remarks given by Secretarial Auditors of the Company. The Secretarial Audit report is annexed to this Annual Report.
Further, the members of the Company, at its Annual General Meeting held on September 4, 2025, have approved the appointment of M/s. MK Saraf & Associates LLP, Practicing Company Secretaries, as secretarial auditors of the Company for a term of five consecutive financial years from April 1, 2025.
SECRETARIAL STANDARDS
During the Financial Year, the Company has complied with the mandatory Secretarial Standards issued by the Institute of Company Secretaries of India.
ACKNOWLEDGEMENT
The Board of Directors place on record its deep appreciation for the co-operation and support of the Company's employees, distributors, wholesalers, retailers, suppliers, business associates, government authorities, bankers, consumers, employees and shareholders and look forward to their continued support on the journey ahead.
On behalf of the Board of Directors
Chittranjan Dua Chairperson DIN:00036080
Date: July 31, 2026 Place: Mumbai
Click here to visit SEBI Scores